Literature DB >> 11772978

Biliary drainage for obstructive jaundice enhances hepatic energy status in humans: a 31-phosphorus magnetic resonance spectroscopy study.

D V Mann1, W W M Lam, N Magnus Hjelm, N M C So, D K W Yeung, C Metreweli, W Y Lau.   

Abstract

BACKGROUND: Biliary obstruction impairs liver function although the pathophysiological mechanism is incompletely understood. AIMS: The aim of this study was to examine serial changes in liver metabolism in patients with obstructive jaundice using image guided in vivo 31-phosphorus magnetic resonance spectroscopy ((31)P MRS). This technique allows repeated and non-invasive assay of organ energy metabolism and phospholipid biochemistry. PATIENTS: We studied 10 patients presenting with obstructive jaundice secondary to extrahepatic localised malignancy. There were eight men and two women, median age 72 years (range 54-94), six with cholangiocarcinoma (all Bismuth type 1) and four with carcinoma of the head of the pancreas. Ten healthy volunteers (median age 24 years (range 21-26)) were studied for comparison.
METHODS: Hepatic metabolism in jaundiced patients was measured by (31)P MRS at presentation and again after a one week period of biliary drainage. Conventional liver function tests were also recorded.
RESULTS: Compared with controls, liver spectra from jaundiced patients contained an excess of phosphomonoester (PME) metabolites (PME/total phosphate median 10.3% (interquartile range 8.7-11.5) in controls, 15.4% (13.1-17.7) in jaundiced cases; p<0.01). Biliary decompression was achieved in all patients (five with internal stents and five by external drainage catheters), and plasma biochemistry improved predictably (bilirubin 176 micromol/l (158-351) at presentation, 110 micromol/l (42-241) after drainage for one week; p<0.01). Enhancement of hepatic energy status, measured by the ratio of adenosine triphosphate (ATP) to inorganic phosphate (Pi), was observed in all cases after relief of biliary obstruction (ATP/Pi 1.4 (1.17-1.69) at presentation, 1.97 (1.4-2.48) after drainage; p<0.01) and was independent of the route of bile drainage. Hepatic phosphodiester (PDE) content was decreased after relief of obstruction (PDE/total phosphate 25.2% (20.5-27.4) at presentation, 19.8% (16.6-24.5) after drainage; p<0.01). This change was probably due to a reduction in the contribution from bile contents to this resonance as a strong PDE signal was also detectable in spectra obtained from separate bile specimens.
CONCLUSIONS: Obstructive jaundice produces alterations in liver phosphoester biochemistry, most likely reflecting disturbances in phospholipid metabolism. Relief of biliary obstruction is associated with a measurable increase in hepatic energy status. Bile may contribute to the phosphodiester signal of the 31-phosphorus liver spectrum and changes in these resonances must therefore be interpreted with caution and in relation to the clinical situation. Monitoring of liver metabolism by (31)P MRS may allow clinicians to refine the selection and timing of therapeutic options in jaundiced patients.

Entities:  

Mesh:

Year:  2002        PMID: 11772978      PMCID: PMC1773079          DOI: 10.1136/gut.50.1.118

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  32 in total

1.  Endoplasmic reticulum: the major contributor to the PDE peak in hepatic 31P-NMR spectra at low magnetic field strengths.

Authors:  E J Murphy; T E Bates; S R Williams; T Watson; K M Brindle; B Rajagopalan; G K Radda
Journal:  Biochim Biophys Acta       Date:  1992-10-19

2.  Prediction of risk in biliary surgery.

Authors:  S L Blamey; K C Fearon; W H Gilmour; D H Osborne; D C Carter
Journal:  Br J Surg       Date:  1983-09       Impact factor: 6.939

3.  Factors affecting morbidity and mortality after surgery for obstructive jaundice: a review of 373 patients.

Authors:  J M Dixon; C P Armstrong; S W Duffy; G C Davies
Journal:  Gut       Date:  1983-09       Impact factor: 23.059

4.  Experimental and clinical studies on the effect of biliary drainage in obstructive jaundice.

Authors:  K Koyama; Y Takagi; K Ito; T Sato
Journal:  Am J Surg       Date:  1981-08       Impact factor: 2.565

5.  Pre-operative percutaneous transhepatic biliary drainage: the results of a controlled trial.

Authors:  G A McPherson; I S Benjamin; H J Hodgson; N B Bowley; D J Allison; L H Blumgart
Journal:  Br J Surg       Date:  1984-05       Impact factor: 6.939

6.  Evaluation of indocyanine green retention and aminopyrine breath tests in patients with malignant biliary obstruction.

Authors:  S T Fan; Q S Wang; C M Lo; K W Tam Yu; E C Lai; J Wong
Journal:  Aust N Z J Surg       Date:  1994-11

7.  Effect of functional grade and etiology on in vivo hepatic phosphorus-31 magnetic resonance spectroscopy in cirrhosis: biochemical basis of spectral appearances.

Authors:  D K Menon; J Sargentoni; S D Taylor-Robinson; J D Bell; I J Cox; D J Bryant; G A Coutts; K Rolles; A K Burroughs; M Y Morgan
Journal:  Hepatology       Date:  1995-02       Impact factor: 17.425

Review 8.  Phospholipid metabolites as indicators of cancer cell function.

Authors:  J Ruiz-Cabello; J S Cohen
Journal:  NMR Biomed       Date:  1992 Sep-Oct       Impact factor: 4.044

9.  A 31P and 1H-NMR investigation in vitro of normal and abnormal human liver.

Authors:  J D Bell; I J Cox; J Sargentoni; C J Peden; D K Menon; C S Foster; P Watanapa; R A Iles; J Urenjak
Journal:  Biochim Biophys Acta       Date:  1993-11-25

10.  Preoperative endoscopic drainage for malignant obstructive jaundice.

Authors:  E C Lai; F P Mok; S T Fan; C M Lo; K M Chu; C L Liu; J Wong
Journal:  Br J Surg       Date:  1994-08       Impact factor: 6.939

View more
  8 in total

1.  Intraoperative simulation of remnant liver function during anatomic liver resection with indocyanine green clearance (LiMON) measurements.

Authors:  Michael N Thomas; Ernst Weninger; Martin Angele; Florian Bösch; Sebastian Pratschke; Joachim Andrassy; Markus Rentsch; Manfred Stangl; Werner Hartwig; Jens Werner; Markus Guba
Journal:  HPB (Oxford)       Date:  2015-01-08       Impact factor: 3.647

Review 2.  Emerging Role for 7T MRI and Metabolic Imaging for Pancreatic and Liver Cancer.

Authors:  Debra Rivera
Journal:  Metabolites       Date:  2022-04-30

3.  Absolute quantification of human liver metabolite concentrations by localized in vivo 31P NMR spectroscopy in diffuse liver disease.

Authors:  Bengt Norén; Peter Lundberg; Marcus Ressner; Staffan Wirell; Sven Almer; Orjan Smedby
Journal:  Eur Radiol       Date:  2004-09-03       Impact factor: 5.315

4.  Hepatic fat and adenosine triphosphate measurement in overweight and obese adults using 1H and 31P magnetic resonance spectroscopy.

Authors:  Steven F Solga; Alena Horska; Susanne Hemker; Stephen Crawford; Charalett Diggs; Anna Mae Diehl; Frederick L Brancati; Jeanne M Clark
Journal:  Liver Int       Date:  2008-03-04       Impact factor: 5.828

Review 5.  Diagnosis and initial management of cholangiocarcinoma with obstructive jaundice.

Authors:  Takashi Tajiri; Hiroshi Yoshida; Yasuhiro Mamada; Nobuhiko Taniai; Shigeki Yokomuro; Yoshiaki Mizuguchi
Journal:  World J Gastroenterol       Date:  2008-05-21       Impact factor: 5.742

6.  Profiling circulating and urinary bile acids in patients with biliary obstruction before and after biliary stenting.

Authors:  Jocelyn Trottier; Andrzej Białek; Patrick Caron; Robert J Straka; Piotr Milkiewicz; Olivier Barbier
Journal:  PLoS One       Date:  2011-07-08       Impact factor: 3.240

7.  Mortality after portal vein embolization: Two case reports.

Authors:  Eung Chang Lee; Sang-Jae Park; Sung-Sik Han; Hyeong Min Park; Seung Duk Lee; Seong Hoon Kim; In Joon Lee; Hyun Beom Kim
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889

8.  Phosphodiester content measured in human liver by in vivo 31 P MR spectroscopy at 7 tesla.

Authors:  Lucian A B Purvis; William T Clarke; Ladislav Valkovič; Christina Levick; Michael Pavlides; Eleanor Barnes; Jeremy F Cobbold; Matthew D Robson; Christopher T Rodgers
Journal:  Magn Reson Med       Date:  2017-02-28       Impact factor: 4.668

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.